Molecular mechanisms controlling pancreatic β cell regeneration and pathophysiological significance of pancreatic nestin-expressing cells
Molecular mechanisms controlling pancreatic β cell regeneration and pathophysiological significance of pancreatic nestin-expressing cells
批准号:
14571063
负责人:
HOSODA Kiminori
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(Purpose) Pancreatic β cell is derived from endoderm. Similarities have been pointed out between pancreatic β cells and neuronal cells. In the present study, we investigated the significance of neurogenin 3 (ngn3), nestin, and notch2.(Methods and Results) NGN3 gene expression was very low in streptozotocin-induced pancreatic β cell regeneration rat model, indicating that ngn3 gene expression is not changed in β cell regeneration. Although ngn3 gene expression was noted in central nervous system of rat embryo, postnatally it was not detected in normal rats and in streptozotocin-induced pancreatic β cell regeneration rat model. Using GFP immunofluorescence and anti-GFP antibody, nestin was expressed in vascular endothelial cells of pancreata of streptozotocin-induced pancreatic β cell regeneration rat model and normal rats. Postnatally, using Notch2-LacZ knock-in mouse and immunohistochemistry of anti-Notch2 antibodies, notch2 is expressed mainly in pancreatic duct cells.(Discussion) Since ngn3 was not detected in postnatal pancreas, the significance of ngn 3 in postnatal pancreatic regeration remains to be elucidated. In the present study, nestin was demonstrated to be expressed in vascular endothelial cells. Since β cell is derived from endodermal origin, nestin-expressing cells appear to be precursors of pancreatic β cells. Pancreatic duct cells has been proposed to be derived from pancreatic duct cells. Notch2-expressing cells may be precursors of β cells. We are investing the significance of notch2 using pancreas-tissue specifc kock-out mice.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Toyoda, K.Hosoda, et al.: "Possible involvement of the {alpha} 1 isoform of 5'AMP-activated protein kinase in oxidative-stress-stimulated glucose transport in skeletal muscle"Am J Physiol Endocrinol Metab.. (in press). (2004)
T.Toyoda、K.Hosoda 等人:“5AMP 激活蛋白激酶的 {α}1 亚型可能参与骨骼肌中氧化应激刺激的葡萄糖转运”Am J Physiol Endocrinol Metab..(
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Ariyasu, K.Hosoda et al.: "Delayed short-term secretory regulation of ghrelin in obese animals : evidence by a specific RIA for the active form of ghrelin"Endocrinology. 143・9. 3341-3350 (2002)
H.Ariyasu、K.Hosoda 等:“肥胖动物中生长素释放肽的短期分泌调节:生长素释放肽活性形式的特定 RIA 的证据”内分泌学 143・9 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
C.Son, K.Hosoda, et al.: "Reduction of diet-induced obesity in mice overexpressing uncoupling protein 3 in skeletal muscle."Diabetologia. 47. 47-54 (2004)
C.Son、K.Hosoda 等人:“骨骼肌中过度表达解偶联蛋白 3 的小鼠可减少饮食引起的肥胖。”糖尿病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Iwakura, K.Hosoda, et al.: "Ghrelin expression in islet cell tumors-augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm typeI."J.Clin.Endocrinot Metab. 87. 4885-4888 (2002)
H.Iwakura、K.Hosoda 等人:“胰岛细胞肿瘤中的 Ghrelin 表达 - 在 I 型多发性内分泌肿瘤的胰高血糖素瘤病例中 Ghrelin 的表达增强。”J.Clin.Endocrinot Metab。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Takahashi-Yasuno, K.Hosoda, et al.: "Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men."Diabetes Res Clin Pract. 63(3). 195-175
A.Takahashi-Yasuno、K.Hosoda 等人:“瘦素受体多态性与日本男性的血清脂质水平和辛伐他汀降低胆固醇作用的损害有关。”糖尿病研究临床实践。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
-
批准号:24659444
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:HOSODA Kiminori
-
依托单位:
Elucidation of molecular mechanisms of insulin secretion disorders secondary to insulin resistance -study of GPR40-
-
批准号:20591094
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:HOSODA Kiminori
-
依托单位:
Elucidation fo molecular mechanism of pancreatic befa ceel differentiation using fissue-specific koock-out mice for the regeneration of beta ceas
-
批准号:18591021
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.48万
-
财政年份:2006
-
负责人:HOSODA Kiminori
-
依托单位:
ELUCIDATION OF SIGNIFICANCE OF UCP3 IN DIABETES AND OBESITY USING TRANSGENIC MICE
-
批准号:12671110
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2000
-
负责人:HOSODA Kiminori
-
依托单位:
Molecular Medicine of Clinical Implication of Obese Gene Product
-
批准号:09671052
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1997
-
负责人:HOSODA Kiminori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
LIPUS响应的弹性石墨烯多孔导管促进神经再生及其机制研究
-
批准号:82370933
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陆家瑜
-
依托单位:
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
-
批准号:82370921
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:徐袁瑾
-
依托单位:
哺乳动物新生期心肌细胞增殖及其调控机制研究
-
批准号:32100592
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:蒲文娟
-
依托单位:
水稻愈伤组织分化相关蛋白的分离及其功能研究
-
批准号:31201189
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2012
-
负责人:朱克明
-
依托单位:
EphB1-ephrinB2在小鼠视神经轴突再生中的导向作用研究
-
批准号:81170837
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:杨柳
-
依托单位:
骨髓源干细胞参与周围神经再生的实验研究
-
批准号:30973050
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:祁佐良
-
依托单位:
Bcl-2转基因小鼠再生视神经向外侧膝状体的生长导向研究
-
批准号:30872835
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2008
-
负责人:杨柳
-
依托单位: